Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell
Yasheng Li, Xi Yang, Dongsheng Zhao, et al.
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113336-113336
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics
Jan Škubník, Vladimíra Svobodová Pavlíčková, Tomáš Ruml, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 849-849
Open Access | Times Cited: 111
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review
Jinyun Dong, Yuan Li, Can Hu, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108488-108488
Closed Access | Times Cited: 73
Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review)
Yichen Tian, Yongrong Lei, Yani Wang, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 5
Open Access | Times Cited: 54
Simplified Derivatives of Tetrandrine as Potent and Specific P-gp Inhibitors to Reverse Multidrug Resistance in Cancer Chemotherapy
Rong Zeng, Xiu‐Ming Yang, Hongwei Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4086-4105
Closed Access | Times Cited: 24
Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7/ADR cell
Zhikun Yang, Disheng Luo, Chen Shao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116207-116207
Closed Access | Times Cited: 10
Molecular Modeling Strategies of Cancer Multidrug Resistance
Gözde Yalçın
Drug Resistance Updates (2021) Vol. 59, pp. 100789-100789
Closed Access | Times Cited: 46
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
Zhikun Yang, Yue Cai, Xue Yang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5550-5566
Closed Access | Times Cited: 19
Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P -glycoprotein expression levels
Laila M. Al-Harbi, Eman Alharbi, Rawda M. Okasha, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
Zhikun Yang, Xue Yang, Yasheng Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115092-115092
Closed Access | Times Cited: 17
Self‐Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma
Yong Li, Qingyu Zhao, Xinyi Zhu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 17
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
Jerónimo Laiolo, Dafni G. Graikioti, Cecilia L. Barbieri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Modular Biomimetic Strategy Enabled Discovery of Simplified Pseudo-Natural Macrocyclic P-Glycoprotein Inhibitors Capable of Overcoming Multidrug Resistance
Bo Liu, Xueni Yu, Liping Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2550-2565
Closed Access | Times Cited: 12
Design, Synthesis, and Biological Activity Study of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives Against Multidrug Resistance in Eca109/Vcr Cells
Qin Ouyang, Bo Xu, Tao Yu, et al.
(2025)
Closed Access
Unraveling the interaction of pyranocoumarins with P-glycoprotein: Implications for overcoming multidrug resistance in cancer therapy
Mohamed H. Helal, Mosa Alsehli, Al-Anood M. Al-Dies, et al.
Bioorganic Chemistry (2025) Vol. 158, pp. 108314-108314
Closed Access
Discovery of pyranocoumarin derivatives as dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P-glycoprotein expression levels and function
Al-Anood M. Al-Dies, Mosa Alsehli, Heba Alsharif, et al.
Journal of Molecular Structure (2025), pp. 142007-142007
Closed Access
Design, Synthesis, and Biological Activity Study of 6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline Derivatives Against Multidrug Resistance in Eca109/VCR Cells
Bo Xu, Tao Yu, Hong-Yuan Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117542-117542
Closed Access
2,5-Disubstituted furan derivatives containing imidazole, triazole or tetrazole moiety as potent α-glucosidase inhibitors
Min He, Yuanjing Li, Jiang Shao, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106298-106298
Closed Access | Times Cited: 12
Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7/ADR cell
Zhikun Yang, Yue Cai, Shen Mao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115462-115462
Closed Access | Times Cited: 7
Discovery of new tricyclic spiroindole derivatives as potent P-glycoprotein inhibitors for reversing multidrug resistance enabled by a synthetic methodology-based library
Tao Yu, Rong Zeng, Yu Guan, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1675-1685
Closed Access | Times Cited: 2
Discovery of (quinazolin-6-yl)benzamide derivatives containing a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety as potent reversal agents against P-glycoprotein-mediated multidrug resistance
Wen-han Xue, Kai-li Liu, Tingjian Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116039-116039
Closed Access | Times Cited: 6
Synthesis of 9-Hydroxy-1H-Benzo[f]chromene Derivatives with Effective Cytotoxic Activity on MCF7/ADR, P-Glycoprotein Inhibitors, Cell Cycle Arrest and Apoptosis Effects
Fawzia F. Albalawi, Mohammed A. A. El-Nassag, Raafat A. El-Eisawy, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 49-49
Open Access | Times Cited: 10
Biological Activities of Tetrahydroisoquinolines Derivatives
Maryam Amra Jordaan, Oluwakemi Ebenezer
Journal of organic and pharmaceutical chemistry (2023) Vol. 21, Iss. 1, pp. 20-38
Open Access | Times Cited: 3
The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers
Elisabetta Teodori, Laura Braconi, Dina Manetti, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 31, pp. 2535-2569
Closed Access | Times Cited: 4
Discovery and SAR Study of Quinoxaline–Arylfuran Derivatives as a New Class of Antitumor Agents
Dongmei Fan, Pingxian Liu, Yunhan Jiang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2420-2420
Open Access | Times Cited: 4
Five-membered ring systems: furans and benzofurans
Halina Kwiecień
Progress in heterocyclic chemistry (2023), pp. 209-253
Closed Access
Page 1 - Next Page

Scroll to top